Compounds > adamantane
Page last updated: 2024-08-21

adamantane and dihydropyridines

adamantane has been researched along with dihydropyridines in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agrawal, KC; Donkor, IO; Kishore, V; Schmidt, J; Zhou, X1
Carminati, P; Chiarucci, I; Diomede, L; Ferrara, FF; Garattini, E; Gianni', M; Kalac, Y; Merlini, L; Parrella, E; Pisano, C; Simoni, D; Terao, M; Zanier, R1
Galun, E; Matot, I; Rivo, J; Zeira, E1

Other Studies

3 other study(ies) available for adamantane and dihydropyridines

ArticleYear
Synthesis and radioprotective effects of adamantyl substituted 1,4-dihydropyridine derivatives.
    Bioorganic & medicinal chemistry, 1998, Volume: 6, Issue:5

    Topics: Adamantane; Animals; Cell Line; Cricetinae; Cricetulus; Dihydropyridines; Magnetic Resonance Spectroscopy; Male; Mice; Radiation-Protective Agents

1998
ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis.
    Blood, 2004, Jan-01, Volume: 103, Issue:1

    Topics: Adamantane; Antineoplastic Agents; Apoptosis; Calcium; Cell Line, Tumor; Chelating Agents; Cinnamates; Dihydropyridines; Egtazic Acid; Gene Expression; HeLa Cells; Homeostasis; Humans; Intracellular Fluid; JNK Mitogen-Activated Protein Kinases; Leukemia, Myeloid; Mitochondria; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids

2004
Activation of A3 adenosine receptors attenuates lung injury after in vivo reperfusion.
    Anesthesiology, 2004, Volume: 101, Issue:5

    Topics: Adamantane; Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; ATP-Binding Cassette Transporters; Cats; Dihydropyridines; Enzyme Inhibitors; Hemodynamics; Histamine; In Vitro Techniques; KATP Channels; Lung; Morpholines; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pulmonary Artery; Reperfusion Injury

2004